StrokeDx Raises $5M in Seed Funding


StrokeDx, a Pasadena, CA-based stroke detection technology company, raised $5M in Seed funding.

The round was led by DigiTx Partners, with participation by Freeflow Ventures and other existing investors with extensive accomplishments across neuroradiology, stroke, and medical devices. David J. Kim, MD, Managing Director of DigiTx Partners, will be joining the board.

The company intends to use the funds for further clinical validation of its technology and the expansion of its commercial efforts.

Led by CEO Alexander Ballatori, StrokeDx specializes in developing advanced technologies and software to enable portable, non-invasive, non-radiating cerebrovascular monitoring. The company’s innovative approach offers a precise method to survey strokes using next-generation technology developed by Shane Shahrestani, MD, PhD, at the California Institute of Technology (Caltech). is at the forefront of developing stroke detection technology.

To date, StrokeDx’s technology has raised almost $10 million, including a National Institutes of Health (NIH) R01 Grant.